CTOs on the Move

Andwin Scientific

www.andwinsci.com

 
Andwin Scientific specializes in product distribution both as a distributor to direct end using companies, and as a supplier/vendor to national and international supply houses. This effort is supported by offices in North Carolina and Illinois
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.andwinsci.com
  • 229 S Mitchell Ct Ste a30
    Addison, IL USA 60101
  • Phone: 800.297.1220

Executives

Name Title Contact Details

Similar Companies

Lac St Anne County

Lac St Anne County is a Sangudo, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Douglas County Hospital

Douglas County Hospital is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Alexandria, MN. To find more information about Douglas County Hospital, please visit www.dchospital.com

Community Network Services

Community Network Services, Inc. (CNS) is a private non-profit human services agency that provides comprehensive behavioral health services. CNS offers a wide spectrum of community-based support services delivered by peer support specialists, psychiatrists, physicians assistants, nurse practitioners, and bachelor and master-level counselors and psychologists. CNS’ services assist consumers with managing their mental illness and gaining maximum independence toward self-worth and recovery. CNS provides social services supports for all aspects of consumers’ lives, reaching well beyond psychiatric or psychotherapeutic interventions.

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.

BioPharm Systems

BioPharm Systems is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.